Clinical Trial Update: Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer

View source ↗

Summary

The trial investigating alopecia as a side effect of endocrine therapy in postmenopausal women with breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Cancer | Status: TERMINATED